Genetic susceptibility to neuroblastoma
- 1 February 2017
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 42, 81-90
- https://doi.org/10.1016/j.gde.2017.03.008
Abstract
No abstract availableFunding Information
- Institutional Clinical and Translational Science Award (TL1 RR024133)
- John Maris’ (R01 CA124709)
This publication has 110 references indexed in Scilit:
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium studyThe Lancet Oncology, 2013
- Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct MechanismsCell, 2011
- Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancerCancer Chemotherapy and Pharmacology, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- A map of human genome variation from population-scale sequencingNature, 2010
- Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mysteryAmerican Journal of Medical Genetics Part A, 2010
- Opposing microRNA families regulate self-renewal in mouse embryonic stem cellsNature, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996